Skip to content

Impact of pediatric epilepsy surgery on healthcare resource use.

Aug 2026 · Epilepsy Research · Vol 227, pp. 107901 · 0 citations · 29 references
Medicine

TL;DR

Among pediatric patients with drug-resistant epilepsy, healthcare resource use substantially decreases after epilepsy surgery, especially when the patient does not require subsequent epilepsy surgeries.

Abstract

Objective

To quantify healthcare resource use before and after epilepsy surgery among pediatric patients with drug-resistant epilepsy, stratifying by type of surgery, type of insurance, race, and ethnicity.

Methods

Retrospective descriptive study of the Pediatric Health Information System (PHIS) database in the period 2004-2024. Our main outcome was healthcare resource use.

Results

1288 patients (median (p25-p75) age at first epilepsy surgery: 11.0 (6.8-15.3) years, 43% females) had a total of 1538 epilepsy surgeries. Although the median (p25-p75) cost of epilepsy surgery was high [$88,512 ($51,283-$145,159)], after epilepsy surgery (versus before epilepsy surgery) there was a decrease in number of hospital admissions per person-year [0.6 (0.2-1.3) versus 1.4 (0.8-2.4), p < 0.0001], days of hospital stay per person-year [1.5 (0.3-5.0) versus 4.4 (2.2-9.1), p < 0.0001], and total healthcare resource use per person-year [$15,571 ($4,465-$44,089) versus $28,100 ($14,723-$58,455), p < 0.0001]. Decreases in healthcare resource use were more pronounced among patients who required only one epilepsy surgery than in patients who needed subsequent epilepsy surgeries. Decreases in healthcare resource use were similar for all types of surgeries except when the first surgery was laser interstitial thermal therapy (LITT) or ablation or radiosurgery (mainly because many of these patients required subsequent surgeries), for all types of insurances, for all races, and for all ethnicities.

Conclusion

Among pediatric patients with drug-resistant epilepsy, healthcare resource use substantially decreases after epilepsy surgery, especially when the patient does not require subsequent epilepsy surgeries. Results were similar for all types of insurance, for all races, and for all ethnicities.

View source

Similar papers

Sep 2026

Severe COVID-19 outcomes in patients with epilepsy: evidence from a nationwide, population-based study in Poland.

OBJECTIVE The course of COVID-19 and its mortality rate largely depend on the presence of comorbidities. The aim of the study was to evaluate the association between epilepsy and severe COVID-19 outcomes in a nationwide cohort of hospitalized patients in Poland. METHODS This retrospective, nationwide, population-base...

Aleksandra Pawlicka, Marcin Kruk, B. Koń et al. · 0 citations
Open access Sep 2026

Mortality in two independent First Seizure Clinic cohorts up to 20 years post epilepsy diagnosis.

BACKGROUND Excess mortality has been demonstrated in individuals with epilepsy. Here, we aimed to examine mortality in patients from two independent First Seizure Clinics (FSCs), up to 20 years after a new epilepsy/unprovoked seizure diagnosis assigned by epileptologists. Patients were also grouped according to pre-exi...

A. McIntosh, Patrick W. Carney, Meng K. Tan et al. · 0 citations
Open access Sep 2026

Utilization of Anti-Seizure Medication (ASMS) and Seizure Control in Pediatric Epilepsy: A Retrospective Cross-Sectional Study in Oman

Objectives: Epilepsy is a chronic neurological disorder associated with substantial morbidity, reduced quality of life, and a considerable global healthcare burden. We aimed to assess anti-seizure medication (ASMS) utilization patterns, adherence levels, and factors influencing seizure control and adverse effects among...

Y. Nomier, Yaqeen Al-Aamri, Rawan Al-Toqi et al. · 0 citations
Open access Jul 2026

Does age influence diagnostic outcomes in an adult cohort referred to a first-seizure clinic?

OBJECTIVE The aging Danish population is associated with increasing morbidity and healthcare utilization. This study examines age-related differences in resource utilization and diagnostic outcomes between older (65-95 years) and younger adults (18-64 years) evaluated for suspected epilepsy, including clinical manageme...

Anne Line Lund Birkmose, Corinna Lackmann, L. Pinborg et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.